Evotec SE: What is the story behind this healthcare stock?

R. Dietenberger
Reading Time: 1 minute

On May 23, Evotec SE (i.) broke out of a multi-week consolidation to a multi-month high amid a significant increase in trading volume and subsequently defended the breakout. I suspect that this price reaction is partly due to the strategic realignment of the company with its two-pillar strategy. The company aims to focus more intensively to achieve an average annual revenue growth of 8-12% and an EBITDA margin of over 20% in its medium-term outlook for 2024-2028. Additionally, acquisition speculation is likely to drive the stock price. Most recently,...

Read this article now with a free account.

Your benefits:

  • Every month, you can read 5 articles from the premium section for free.
  • Monthly 2 trial issues of the Trader newspaper for free.
  • Create a personal watchlist with an overview of news about your stock.
Trader Times
Free account
Here we go!
Image 1Image 2Image 3

Already registered? Log In